CLIP 86-100 acetate(648881-58-7 free base)

TargetMol
Product Code: TAR-TP1573L
Supplier: TargetMol
CodeSizePrice
TAR-TP1573L-1mg1mg£145.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1573L-2mg2mg£177.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1573L-5mg5mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1573L-10mg10mg£307.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1573L-25mg25mg£507.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1573L-50mg50mg£699.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1573L-100mg100mg£946.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
This is amino acids 86 to 100 fragment of class II-associated invariant chain peptide called CLIP. The major histocompatibility complex class II molecule displays peptide fragments of foreign proteins to trigger a defensive reaction from the immune system. Before insertion of the foreign peptides into the binding groove, a place-holding peptide CLIP is removed. This is accomplished by the molecule DM, which is shown to increase the dissociation rate of a CLIP peptide from class II.
CAS:
TP1573L
Formula:
C74H132N20O21S3
Molecular Weight:
1734.17
Purity:
0.995
SMILES:
C[C@@H](C(O)=O)NC([C@H](CCC(N)=O)NC([C@H](CCSC)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H]1N(C([C@H]([C@H](O)C)NC([C@H](C)NC([C@H](CCSC)NC([C@H](CCCNC(N)=N)NC([C@H](CCSC)NC([C@H](CCCCN)NC([C@H](CO)NC([C@H](C(C)C)NC([C@H]2NCCC2)=O)=O)=O)=O)=O)=O)=O)=O)=O)CCC1)=O)=O)=O)=O)=O.CC(O)=O

References

van Luijn MM, et al. Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia. Oncoimmunology. 2015 Jan 7;3(12):e941737. eCollection 2014 Dec.